Kyoto, Japan

Hirotaka Wada

This inventor holds 32 USPTO granted patents and 22 published patent applications and 14 EPO patents, primarily in Textile Machinery. Top assignees: Omron Corporation, Murata Machinery, Ltd., Omron Healthcare Company Ltd.. Active years: 2010-2026.

USPTO Granted Patents = 32 

% Patents Active = 87.5

 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Nara, JP (2010 - 2020)
  • Kyoto, JP (2020 - 2024)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Yarn Path Guide
Filament Winding
Blood Pressure Detection
Motion Analysis
Biological Information
Document Creation
Image Processing
Causal Network Generation
Electrocardiograph
Textile Machine
User Terminal
Board Inspection
32 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hirotaka Wada

Introduction: Hirotaka Wada, a pioneering inventor hailing from Kyoto, Japan, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Hirotaka Wada's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles and cutting-edge medical devices for minimally invasive surgeries.

Career Highlights: With a career spanning over two decades, Hirotaka Wada has worked with top research institutions and leading tech companies to develop revolutionary solutions in the fields of robotics, healthcare, and renewable energy.

Collaborations: Throughout his career, Hirotaka Wada has collaborated with renowned scientists, engineers, and designers to bring his visionary ideas to life. His collaborative spirit has led to the creation of patented technologies that have transformed industries.

Conclusion: Hirotaka Wada's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…